| Yu, Hong Jeng |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). |
|
|
| Active, not recruiting | 3 | 270 | Europe, Canada, US, RoW | NovoTTF-200M device, Best Standard of Care | NovoCure GmbH | Brain Metastases From Non-small Cell Lung Cancer (NSCLC) | 12/24 | 12/24 | | |
NCT06322394: BXOS110 Injection in the Treatment of Acute Ischaemic Stroke |
|
|
| Recruiting | 2 | 300 | RoW | high-dose BXOS110, BXOS110, low-dose BXOS110, Placebo | Biocells (Beijing) Biotech Co.,Ltd | Acute Ischemic Stroke | 03/25 | 09/25 | | |
NCT06327230: The Application of Thoracic Epidural Analgesia in Patients With Acute Pancreatitis |
|
|
| Active, not recruiting | N/A | 88 | RoW | Thoracic Epidural Analgesia | Sir Run Run Shaw Hospital | Acute Pancreatitis | 12/25 | 04/26 | | |
| Recruiting | N/A | 5000 | US | Stereotactic brain procedures | Vanderbilt University Medical Center, National Institute for Biomedical Imaging and Bioengineering (NIBIB), National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Mental Health (NIMH) | Parkinson's Disease, Obsessive Compulsive Disorder, Dystonia, Essential Tremor, Epilepsy | 07/25 | 07/25 | | |
| Wang, Rui |
NCT04344158: A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) |
|
|
| Not yet recruiting | 3 | 648 | RoW | AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate Tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Hepatocellular Carcinoma (HCC) | 06/24 | 12/24 | | |
| Active, not recruiting | 3 | 2024 | US | vitamin D, vitamin D3, cholecalciferol, Placebo | Brigham and Women's Hospital, Harvard Medical School (HMS and HSDM), Harvard School of Public Health (HSPH), Fenway Health and Beth Israel Deaconess Medical Center, Tishcon Corporation, Takeda, Quest Diagnostics-Nichols Insitute, Laboratory Corporation of America, Trialfacts, Karolinska Institutet, Philanthropic donations | COVID-19 | 07/24 | 07/24 | | |
| Recruiting | 3 | 516 | RoW | Tirofiban, Tirofiban Hydrochloride and Sodium Chloride Injection, Aspirin tablet, Clopidogrel tablet | Peking Union Medical College Hospital, Pharmaron (Chengdu) Clinical Services Co., Ltd. | Branch Atheromatous Disease | 07/25 | 10/25 | | |
NCT04866862: Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer |
|
|
| Recruiting | 2 | 32 | RoW | Combination of Fruquintinib and Camrelizumab, Fruquintinib 5mg d1-21+Camrelizumab 200 mg d1 | The First Affiliated Hospital with Nanjing Medical University | Colorectal Neoplasm | 06/24 | 06/24 | | |
NCT06225804: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer |
|
|
| Recruiting | 1 | 164 | US, RoW | ABSK112, EGFR Exon20 inhibitor | Abbisko Therapeutics Co, Ltd | Non-Small Cell Lung Cancer | 03/27 | 03/28 | | |
NCT04883177: Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101) |
|
|
| Completed | N/A | 1000 | RoW | | Hepatopancreatobiliary Surgery Institute of Gansu Province, LanZhou University, Huashan Hospital, The Sixth People's Hospital of Shenyang City, Xingtai City People's Hospital, Jinchang Central Hospital, Baoding People's Hospital, The Third People's Hospital of Zhenjiang City, Shanxi Bethune Hospital, Wuhan Jinyintan Hospital, Jincheng People's Hospital, The Third People's Hospital of Tibet Autonomous Region, People's Hospital of Ningxia Hui Autonomous Region, Fuling Central Hospital of Chongqing City, Hospital of the Chengdu Office of the People's Government of Tibet Autonomous Region, The Central Hospital of Lishui City, The Third People's Hospital of Linfen City, Yibin First People's Hospital, Jingzhou Central Hospital, Wuxi Fifth People's Hospital, Qingyang People's Hospital, The First Affiliated Hospital of Anhui Medical University, Beilun Hospital of Traditional Chinese Medicine, Henan Provincial People's Hospital, Qingdao Sixth People's Hospital, The First Affiliated Hospital of Xiamen University, Shandong Provincial Hospital, Beijing YouAn Hospital, The First People's Hospital of Taicang, The Third People's Hospital of Taiyuan, Tianjin Second People's Hospital, Tianjin Third Central Hospital, Qishan Hospital of Yantai City, Affiliated Hospital of Yunnan University, The First People's Hospital of Yunnan, The Fourth Affiliated Hospital of Zhejiang University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Chongqing Medical University | COVID-19, Liver Disease, Vaccine Reaction | 01/22 | 05/22 | | |
NCT04664010: Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19) |
|
|
| Completed | N/A | 30 | RoW | Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste, fumigation/inhalation of vitamin C, Western medicine treatment, Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and 5% glucose, Traditional Chinese medicine treatment plus Western medicine treatment, Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and high-dose vitamin C treatment, Traditional Chinese medicine treatment plus Western medicine treatment plus Bolus administration of vitamin C | Xi'an International Medical Center Hospital | COVID-19 | 09/22 | 09/23 | | |
NCT04139733: Early Use of Prone Position in ECMO for Severe ARDS |
|
|
| Recruiting | N/A | 160 | RoW | Prone positon, Supine positon | Beijing Chao Yang Hospital | Respiratory Distress Syndrome, Adult | 09/24 | 10/24 | | |
NCT06152744: Evaluation of Membrane Lung Function in High-altitude Regions |
|
|
| Recruiting | N/A | 40 | RoW | Monitoring membrane lung function at different altitudes | Beijing Chao Yang Hospital, Affiliated Hospital of Qinghai University | Extracorporeal Membrane Oxygenation, Membrane Lung Function, High Altitude | 10/24 | 11/24 | | |
NCT05765760: Improvement of ARDS Ventilation-perfusion Matching by Prone Positioning Assessed by EIT |
|
|
| Recruiting | N/A | 42 | RoW | | Beijing Chao Yang Hospital | Acute Respiratory Distress Syndrome, Prone Position, Electrical Impedance Tomography | 12/24 | 03/25 | | |
NCT06062212: Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO |
|
|
| Recruiting | N/A | 100 | RoW | Transpulmonary pressure | Beijing Chao Yang Hospital | Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, Mechanical Power, Transpulmonary Mechanical Power | 09/24 | 12/24 | | |
NCT05759832: Modified HFNC Therapy for ARF Patients Undergoing Flexible Bronchoscopy |
|
|
| Recruiting | N/A | 140 | RoW | Modified HFNC oxygen therapy, Face mask | Beijing Chao Yang Hospital | Acute Hypoxemic Respiratory Failure, High-flow Nasal Cannula Oxygen | 12/24 | 05/25 | | |
NCT05822869: Early PP Monitored by EIT in Patients With ARDS |
|
|
| Recruiting | N/A | 60 | RoW | EIT-guided mechanical ventilation strategy, Lung protective ventilation group | Beijing Chao Yang Hospital | Acute Respiratory Distress Syndrome | 04/25 | 12/25 | | |
| Zhang, Jinliang |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
| Han, Shugen |
| Completed | 3 | 1412 | RoW | Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA | Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital | Acute Ischemic Stroke | 06/23 | 06/23 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
| He, Ruili |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
| Zhang, Shuyun |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 04/24 | 04/25 | | |
DRRRI, NCT05866250: Dynamic Change of Doppler-based Renal Resistive Index in Predicting Renal Recovery |
|
|
| Completed | N/A | 467 | RoW | Doppler-based renal resistive index | The First Hospital of Jilin University | Acute Kidney Injury | 12/23 | 03/24 | | |
